MEDIDAS DE CONTROL Y CALIDAD DE VIDA EN EL ASMA
Resumen
RESUMEN
El control del asma se ha definido como el grado en que se pueden reducir o eliminar las manifestaciones de la enfermedad con un adecuado tratamiento. Las guías internacionales de manejo del asma recomiendan monitorizar el control del asma por medio de la evaluación de los síntomas, la función pulmonar y algunos marcadores inflamatorios.
No existe un único método ideal para la monitorización del control, cada uno tiene fortalezas y debilidades, sin embargo, la irrupción de los cuestionarios de control y de calidad de vida han permitido conocer el impacto del asma desde la perspectiva del paciente.
En las últimas dos décadas se han desarrollado y validado numerosos cuestionarios de control y calidad de vida en asma. Los más importantes han sido publicados en diferentes revistas de literatura médica, cumpliendo con los requisitos para un estudio de validación.
El presente trabajo es una revisión bibliográfica que incluye los cuestionarios más relevantes de control y calidad de vida analizándose las características más importantes con el objetivo de identificar su utilidad y sus inconvenientes y la correlación entre ellos.
Referencias
BIBLIOGRAFÍA
Global Initiative for Asthma. Global strategy for asthma management and prevention 2006. Available from https://ginasthma.org/wp-content/uploads/2019/01/2006-GINA.pdf
Taylor DR, Bateman ED, Boulet LP, Boshey HA, Busse WW, Casale TB et al. A new perspective on concepts of asthma severity and control. Eur Respir J 2008; 32: 545-554.
Gema 5.0. Guía española para el manejo del asma. Luzán 5, S. A. de Ediciones. Madrid; 2020. Disponible en URL: https://www.gemasma.com/sites/default/files/2020-05/GEMA_50_ok_25.05.20_red.pdf
Chen H, Gould MK, Blanc PD, Miller DP, Kamath TV, Lee JH, Sullivan SD; for the TENOR Study Group. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007; 120: 396-402.
Nathan RA, Sorkness CA, Kosinski M. Development of the Asthma Control Test: A survey for assessing asthma control. J Allergy Clin Immunol. 2004; 113: 59-65.
Vega JM, Badia X, Badiola C, López-Viña A, Olaguíbel JM, Picado C et al. Validation of the Spanish version of the Asthma Control Test (ACT). J Asthma. 2007; 4: 867-872.
Monteiro de Aguiar M, Rizzo JA, de Melo EF. Validation of the Asthma Control Test in pregnant asthmatic women. Respiratory Medicine 2014; 108: 1589-1593
Soler X, Holbrook J, LB, et al. Validity of the Asthma Control Test Questionnaire Among Smoking Asthmatics. J Allergy Clin Immunol Pract. 2018;6(1):151-158. doi: 10.1016/j.jaip.2017.05.010.
Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999; 14902-14907.
Picado C, Badiola C, Perulero N, Sastre J, Olaguíbel JM, López Viña A, Vega JM. Covalair Investigator Group. Validation of the Spanish version of the Asthma Control Questionnaire. Clin Ther. 2008; 30(10): 1918-1931.
Hallstrand TS, Martin DP, Hummel JP, Williams BL, LoGerfo JP. Initial test of the Seattle Asthma Severity and Control Questionnaire: a multidimensional assessment of asthma severity and control. Annals of Allergy, Asthma & Immu¬nology. 2009; 103(3): 225-232.
Ahmed S, Ernst P, Tamblyn R, Colman N. Validation of The 30 Second Asthma Test™ as a measure of asthma control. Can Respir J. 2007; 14(2): 105-109.
Katz PP, Yelin EH, Smith S, Blanc PD. Perceived control of asthma: deve¬lopment and validation of a questionnaire. Am J Respir Crit Care Med. 1997; 155(2): 577-582.
Vollmer WM. Assessment of asthma control and severity. Ann Allergy Asth¬ma Immunol. 2004; 93(5): 409-413; cuestionario: 414-416, 492.
LeBlanc A, Robichaud P, Lacasse Y, Boulet LP. Quantification of asthma control: validation of the Asthma Control Scoring System. Allergy. 2007; 62(2): 120-125.
Bime C, Wei CY, Holbrook JT, Sockrider MM, Revicki DA, Wise RA. Asth¬ma symptom utility index: reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients. J Allergy Clin Immunol. 2012; 130(5): 1078-1084.
Patino CM, Okelo SO, Rand CS, Riekert KA, Krishnan JA, Thompson K et al. The Asthma Control and Communication Instrument: a clinical tool develo¬ped for ethnically diverse populations. J Allergy Clin Immunol. 2008; 122(5): 936-943.
Tohda Ya, Hozawa S, Tanaka H. Examination of the cut-off values for a questionnaire used to evaluate asthma control in Japanese asthma patients. Allergology International 2019; 68: 46-51
Thomas M, Kay S, Pike J, Williams A, Carranza Rosenzweig JR, Hillyer EV, et al. The Asthma Control TestTM (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Resp J 2009; 18(1): 41 - 49. Doi: 10.4104/pcrj.2009.00010.
Juniper E, Bousquet J, Abetz L, Bateman E. GOAL Committee. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire Respir Med. 2006 ;100(4):616-21
Jia CE, Zhang HP, Lv Y, Liang R, Jiang YQ, Powell H, et al. The Asthma Control Test and Asthma Control Questionnaire for assessing asthma control: Systematic review and meta-analysis. J Allergy Clin Immunol 2013. 131(3): 695-703.
Sastre J, Olaguibel J, Vega JM, del Pozo V, Picado C, Lopez-Viña A. Cut-off points for defining asthma control in three versions of the Asthma Control Questionnaire. J Asthma 2010 Oct;47(8):865-70. doi: 10.3109/02770903.2010.491149.
Olaguibel JM, Quirce S, Juliá B, et al. on behalf of the MAGIC Study Group. Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire. Respiratory Research 2012, 13:50.
Alvarez-Gutiérrez FJ, Medina-Gallardo JF, Pérez-Navarro P, et al. Relación del test de control del asma (ACT) con la función pulmonar, niveles de óxido nítrico exhalado y grados de control según la Iniciativa Global para el Asma (GINA) Arch Bronconeumol. 2010; 46(7):370–377.
Sims EJ,Price D, Haughney J,Ryan D,Thomas M. Current Control and Future Risk in Asthma Management. Allergy Asthma Immunol Res. 2011 October;3(4):217-225.
Bateman ED, Reddel HK, Eriksson G et al. Overall asthma control: The relationship between current control and future risk. J Allergy Clin Immunol 2010;125:600-8.
Meltzer EO, Busse WW, Wenzel SE. Use of the Asthma Control Questionnaire to predict future risk of asthma exacerbation. J Allergy Clin Immunol 2011;127:167-72
Cajigal S, Wells KE, Peterson EL, et al. Predictive Properties of the Asthma Control Test and Its Component Questions for Severe Asthma Exacerbations. J Allergy Clin Immunol Pract. 2017;5(1):121-127.e2. doi:10.1016/j.jaip.2016.06.025
Melosini L, Dente FL, Bacci E, Bartoli ML, Cianchetti S, Costa F, et al. Asthma control test (ACT): comparison with clinical, functional, and biological markers of asthma control. J Asthma. 2012;49:317–23.
Park SY, Yoon SY, Shin B, Kwon HS, Kim TB, Moon HB, et al. Clinical factors affecting discrepant correlation between asthma control test score and pulmonary function. Allergy Asthma Immunol Res. 2015;7:83–7.
Vennera MC, Picado C, Herráez L et al. Factors Associated With Severe Uncontrolled Asthma and the Perception of Control by Physicians and Patients. Arch Bronconeumol. 2014;50(9):384–391
Ko FW, Hui DS, Leung TF, et al. Evaluation of the asthma control test: a reliable determinant of disease stability and a predictor of future exacerbations. Respirology 2012 Feb;17(2):370-8. doi: 10.1111/j.1440-1843.2011.02105.x.
Sullivan PW, Ghushchyan VH, Marvel J, et al. Association Between Pulmonary Function and Asthma Symptoms. J Allergy Clin Immunol Pract. Sep-Oct 2019;7(7):2319-2325.
Werner CU, Linde K, Schäffner J, Storr C, Schneider A. Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients. Primary Care Respiratory Medicine (2017) 27:64
Ferreira DS, Carvalho-Pinto RM, Gregório MG, Annoni R, Teles AM, Buttignol M, et al. Airway pathology in severe asthma is related to airflow obstruction but not symptom control. Allergy. 2018; 73(3): 635-643.
Sato R, Tomita K, Sano H, et al. The strategy for predicting future exacerbation of asthma using a combination of the Asthma Control Test and lung function test. J Asthma 2009 Sep;46(7):677-82. doi: 10.1080/02770900902972160.
Bora M, Alpaydin AO, Yorgancioglu A et al. Does asthma control as assessed by the asthma control test reflect airway inflammation?. Multidisciplinary Respiratory Medicine 2011; 6(5): 291-298
Berstein JA, Davis B, Alvarez-Puebla MJ et al. Is exhaled nitric oxide a useful adjunctive test for assessing asthma?. J Asthma 2009 Nov;46(9):955-60. doi: 10.3109/02770900903265804.
Plaza V,Ramos-Barbón D, Muñoz AM, Fortuna Am,Crespo A, Murio C, Palomino R, on behalf of the EOLO Study Investigators. Exhaled Nitric Oxide Fraction as an Add-On to ACQ-7 for Not Well Controlled Asthma Detection. Plos One. 2013; 8(10): e77085.
Demarche SF,Schleich FN, Paulus VA, et al. Asthma Control and Sputum Eosinophils: A Longitudinal Study in Daily Practice. J Allergy Clin Immunol Pract 2017;5:1335-43
Andrade Almeida PC, Souza-Machado A, dos Santos Leite M et al. Comparison between two methods of asthma control evaluation based on individual perception. J Bras Pneumol. 2012;38(3):299-307
Urrutia I, Plaza V, Pascual S, Cisneros C, Entrenas LM, Luengo MT,et al. Asthma control and concordance of opinions between patientsand pulmonologists. J Asthma. 2013; 50(8): 877-883.
van der Molen T, Fletcher M, Price D. Identifying Patient Attitudinal Clusters Associated with Asthma Control: The European REALISE Survey. J Allergy Clin Immunol Pract 2018;6:962-71
Burbank Aj , Todoric K, Steele P. Age and African-American race impact the validity and reliability of the asthma control test in persistent asthmatics. Respiratory Research (2018) 19:152
Schatz M, Sorkness CA, Li JT et al. Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006;117:549-56
van der Meer V, van Stel HF, Bakker MJ et al. Weekly self-monitoring and treatment adjustment benefit patients with partly controlled and uncontrolled asthma: an analysis of the SMASHING study. Respiratory Research 2010, 11:74
Calvo E, Trigueros JA, López A, Sánchez G. Control del asma en pacientes que acuden a consulta de atención primaria en España (estudio ACTIS). Aten Primaria. 2017;49(10):586-592
Quiralte Enriquez J, Sánchez Herrero G, Loper Peral JC, Aracil J. Impacto de la administración del cuestionario Asthma Control Test en atención primaria sobre la puntuación de control del asma. Aten Primaria. 2013;45(10):522-527
van der Meer A-K, Pasma H, Kempenaar-Okkema W et al. 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use. Eur Respir J 2016; 48: 726–733
Blanco Aparicio M, Delgado Romero J, Molina Paris J et al. . Criterios de derivación en asma: Documento de consenso. Med Gen Fam. 2019; 8(1): 32-40
Trevor JL, Chipps B. Severe Asthma in Primary Care: Identification and Management. The American Journal of Medicine 2018; 131: 484–491
Patil B, Eti A, Lolly M, Khan S, Bansal A. A clinical evaluation of asthma control test to assess the control of asthma and its relation to the severity of asthma. Int J Health Allied Sci 2018;7:12-6.
Alvarez-Gutierrez FJ, Blanco M, Plaza V et al. Documento de consenso de asma grave en adultos. Actualización 2020.Open Respir Arch. In press. Available online 8 May 2020
V. Plaza , S. Quirce, J. Delgado , E. Martínez Moragón , L. Pérez de Llano. Debate multidisciplinar de expertos. Asma no controlada: causas, consecuencias y posibles soluciones An. Sist. Sanit. Navar. 2016; 39 (3): 357-370
Chongmelaxme B, Lee S, Dhippayom T, Saokaew S, Chaiyakunapruk N, Dilokthornsakul P. The Effects of Telemedicine on Asthma Control and Patients’ Quality of Life in Adults: A Systematic Review and Meta-analysis. J Allergy Clin Immunol Pract. 2019; 7: 199-216. e11. Doi: 10.1016/j.jaip.2018.07.015.
McLean G, Murray E, Band R, Moffat KR, Hanlon P, Bruton A, et al. Interactive digital interventions to promote self-management in adults with asthma: systematic review and meta-analysis. BMC Pulm Med. 2016; 16(1): 83
Schatz M, Mosen DM, Kosinski M, et al. Validity of the Asthma Control Test completed at home. Am J Manag Care. 2007 Dec;13(12):661-7.
Ko FW, Leung TF, Hui DS, et al. Asthma Control Test correlates well with the treatment decisions made by asthma specialists.Respirology 2009 May;14(4):559-66. doi: 10.1111/j.1440-1843.2009.01514.x. Epub 2009 Mar 25.
O’Connor RD, Bleecker ER, Long A, Tashkin D, Peters S, Klingman D, Gutierrez B. Subacute lack of asthma control and acute asthma exacerbation history as predictors of subsequent acute asthma exacerbations: evidence from managed care data. J Asthma 2010;47: 422-8.
Stephenson JJ, Quimbo RA, Gutierrez B. Subacute lack of asthma control as a predictor of subsequent acute asthma exacerbation in a managed care population. Am J Manag Care 2010;16:108-14.
World Health Organization División Of Mental Health. Quality of life assesement. WHO/MNH/PSF 94.1, Genova World Health Organization 1994.
Elías Hernández T, Gonzalez Vergara D. Calidad de vida aplicada a la Neumología. En: Manual de diagnóstico y terapéutica en Neumologia. Neumosur 2016; p 113-125
Martínez Moragón E, Perpiñá Tordera M. Cuestionarios sobre calidad de vida. En: Manual SEPAR de procedimientos 34: Cuestionarios de utilidad en el asma bronquial, 2017; p.38-43
Ferrer M, Alonso J, Prieto L, Plaza V, Monsó E, Marrades R, et al. Validity and reliability of the St George’s respiratory questionnaire after adaptation to different language and culture: The spanish example. Eur Respir J 1996; 9: 1160-1166.
Marks GB, Dunn SM, Woolcock AJ. A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol. 1992; 45: 461-472.
Juniper EF, Guyatt GH, Epstein SR, Ferrie PJ, Jaeschke R, Hiller TK. Evalua¬tion of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992; 47: 76-83.
Perpiñá M, Belloch A, Pascual LM, De Diego A, Compte L. Calidad de vida en el asma: validación del cuestionario AQLQ para su utilización en población española. Arch Broconeumol. 1995; 35: 211-218.
Adams RJ, Ruffin RE, Smith BJ. Validity of a modified version of the Marks Asthma Quality of Life Questionnaire. J Asthma. 2000; 37: 131-143.
Sanjuás C, Alonso J, Sanchis J, Casán P, Broquetas MJ, Ferrie PJ et al. Cues¬tionario de calidad de vida en pacientes con asma: la versión española del Asthma Quality of Life Questionnaire. Arch Bronconeumol. 1995; 31: 219-226.
Ware JE Jr, Kemp JP, Buchner DA, Singer AE, Nolop KB, Goss TF. Qual Life Res. 1998 Apr;7(3):235-44.
Van der Molen T, Postma DS, Schreurs AJ, Bosveld HE, Sears MR, Meyboom de Jong B. Qual Life Res. 1997 May;6(4):353-61.
Van der Molen T, Sears MR, de Graaff CS, Postma DS, Meyboom-de Jong B. Eur Respir J. 1998 Jul; 12(1):30-4.
Sanjuas C, Alonso J, Prieto L, Ferrer M, Broquetas JM, Antó JM. Health-related quality of life in asthma: a comparison between St George’s Respiratory Questionnaire and the Asthma Quality of Life Questionnaire. Qual Life Res 2002; 11 (8): 729-738.
Bateman E, Esser D, Chirila C. Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: Systematic review and network meta-analysis.J Allergy Clin Immunol 2015;136:914-22.
Colombo GL, Di Matteo G, Martinotti Ch et al. Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review. Ther Adv Respir Dis 2019, Vol. 13:1753466619841350. doi: 10.1177/1753466619841350.
Caminati M, Le Pham D ,Bagnasco D, Canonica GW. Type 2 immunity in asthma. World Allergy Organ J 2018; 11(1): 13.
Gonzalez-Barcala FJ, de la Fuente-Cid R, Tafalla M, Nuevo J, Caamaño-Isorna F. Factors associated with health-related quality of life in adults with asthma. A cross-sectional study. Multidiscip Respir Med. 2012 Oct 2;7(1):32.
Sundh J, Wireklint Ph, Hasselgren M et al. Health-related quality of life in asthma patients - A comparison of two cohorts from 2005 and 2015. Respiratory Medicine 132 (2017) 154–160
Crespo-Lessmann A, Plaza V, González-Barcala F-J, et al. Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate–severe asthma. BMJ Open Resp Res 2017;4:e000189. doi:10.1136/ bmjresp-2017-000189
Steele AM, Meuret AE, Millard MW,Ritz T. Discrepancies between lung function and asthma control: Asthma perception and association with demographics and anxiety.Allergy Asthma Proc. 2012 Nov-Dec; 33(6): 500–507.
Coban H, Aydemir Y. The relationship between allergy and asthma control, quality of life, and emotional status in patients with asthma: A cross-sectional study. Allergy Asthma Clin Immunol. 2014;10:67.
Takeda T, Oga T, Niimi A, et al. Relationship between Small Airway Function and Health Status, Dyspnea and Disease Control in Asthma Respiration 2010;80:120–126.
Eanes Delgado Barros Pereira, Antonio George de Matos Cavalcante, Eduardo Nolla Silva Pereira. Asthma control and quality of life in patients with moderate or severe asthma. J Bras Pneumol. 2011;37(6):705-711
Volbeda F, Broekema M, Lodewijk ME. Clinical control of asthma associates with measures of airway inflammation. Thorax 2013;68:19–24.
Menezes Pizzichini MM, Cinara Rocha C, de Souza Tavares MG,et al. How does the GINA definition of control correlate with quality of life and sputum cellularity?. ERJ Open Research 2019 5: 00146-2018; DOI: 10.1183/23120541.00146-2018
Enlaces refback
- No hay ningún enlace refback.